55°48′06″N 37°27′27″E / 55.8017°N 37.4576°E
![]() | |
Formation | 1891 | (as N. F. Gamaleya Federal Research Center for Epidemiology & Microbiology)
---|---|
Founder | Filipp Blymenthal[1] |
Purpose | Fund vaccine development |
Headquarters | 18 Gamaleya Street Moscow, Russia 123098 |
Director General | Alexander Gintsburg |
Parent organization | Ministry of Health of the Russian Federation |
Staff | 379 (including 92 professors)[2][3] |
Website | gamaleya gamaleya |
The Gamaleya Research Institute of Epidemiology and Microbiology,[note 1] previously the N. F. Gamaleya Federal Research Center for Epidemiology & Microbiology, is a Russian medical-research institute within the Ministry of Health of the Russian Federation.[note 2]
Founded in 1891 by Filipp Markovich Blyumental,[4] it is named after Soviet scientist Nikolay Fyodorovich Gamaleya (1859–1949), famed as a pioneer in microbiology and in vaccine research. The institute is best known internationally for developing the earliest vaccine for SARS-CoV-2, in collaboration with the 48th Central Research Institute of the Ministry of Defence and the Vector Institute of the Rospotrebnadzor, in response to the COVID-19 pandemic.[5][6]
Cite error: There are <ref group=note>
tags on this page, but the references will not show without a {{reflist|group=note}}
template (see the help page).